Ditchcarbon
  • Contact
  1. Organizations
  2. Cipla USA Inc.
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated 9 months ago

Cipla USA Inc. Sustainability Profile

Company website

Cipla USA Inc., a subsidiary of the renowned global pharmaceutical company Cipla Limited, is headquartered in the United States and operates extensively across North America. Founded in 1935, Cipla has established itself as a leader in the pharmaceutical industry, focusing on the development, manufacturing, and distribution of a diverse range of high-quality generic and branded medications. Cipla USA is particularly noted for its commitment to providing affordable healthcare solutions, specialising in areas such as respiratory, oncology, and anti-infective therapies. The company’s innovative approach to drug formulation and delivery sets it apart in a competitive market. With a strong emphasis on research and development, Cipla USA has achieved significant milestones, including numerous FDA approvals, solidifying its position as a trusted provider of essential medicines.

DitchCarbon Score

How does Cipla USA Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

47

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

34

Industry Benchmark

Cipla USA Inc.'s score of 47 is higher than 69% of the industry. This can give you a sense of how well the company is doing compared to its peers.

69%

Let us know if this data was useful to you

Cipla USA Inc.'s reported carbon emissions

Inherited from Cipla Limited

Cipla USA Inc., headquartered in the US, currently does not have specific carbon emissions data available for the most recent year, as indicated by the absence of emissions figures. The company is a current subsidiary of Cipla Limited, which may influence its climate commitments and performance metrics. Cipla USA Inc. inherits its climate-related data from its parent company, Cipla Limited, at a cascade level of 1. However, no specific reduction targets or initiatives have been documented for Cipla USA Inc. itself. The absence of documented reduction targets suggests that the company may be aligning its climate strategy with broader corporate initiatives set by Cipla Limited. As part of its corporate family, Cipla USA Inc. may benefit from the sustainability practices and commitments of Cipla Limited, which is actively engaged in addressing climate change. Nonetheless, without specific emissions data or reduction targets, it is challenging to assess Cipla USA Inc.'s individual impact or commitments in the context of carbon emissions and climate action.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20182019202020212022202320242025
Scope 1
48,146,000
000,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
Scope 2
236,358,000
00,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
Scope 3
-
-
-
-
-
-
0,000,000,000
0,000,000,000

How Carbon Intensive is Cipla USA Inc.'s Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Cipla USA Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Cipla USA Inc.'s Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Cipla USA Inc. is in US, which has a low grid carbon intensity relative to other regions.

Cipla USA Inc.'s Scope 3 Categories Breakdown

Cipla USA Inc.'s Scope 3 emissions, which increased by 10% last year and increased by approximately 10% since 2024, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Use of Sold Products" being the largest emissions source at 53% of Scope 3 emissions.

Top Scope 3 Categories

2025
Use of Sold Products
53%
Purchased Goods and Services
42%
Upstream Transportation & Distribution
2%
Fuel and Energy Related Activities
1%
Capital Goods
<1%
Employee Commuting
<1%
Waste Generated in Operations
<1%
Business Travel
<1%
Upstream Leased Assets
<1%
Processing of Sold Products
<1%

Cipla USA Inc.'s Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Cipla USA Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Cipla USA Inc.'s Emissions with Industry Peers

Par Pharmaceutical

US
•
Pharmaceutical Preparation Manufacturing
Updated 2 months ago

Ipsen

FR
•
Pharmaceutical Preparation Manufacturing
Updated 10 days ago

Lupin Pharmaceuticals, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 2 months ago

Teva Pharmaceuticals

IL
•
Pharmaceutical Preparation Manufacturing
Updated 7 days ago

Eli Lilly and Company

GB
•
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Sun Pharmaceutical Industries

IN
•
Pharmaceutical Preparation Manufacturing
Updated 18 days ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251120.2
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
Available onAWS Marketplace logo
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy